Arbios Systems Presentation at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference to be Webcast Live LOS ANGELES, April 27 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC:ABOS), a biomedical device company developing proprietary liver assist devices for the treatment of liver failure, today announced that Amy Factor, Chief Executive Officer of Arbios Systems, will be presenting at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference on Wednesday, May 4, 2005 in Paris at 9:25am local time (3:25am Eastern Time). The presentation will be webcast live and can be accessed through the Company's website at http://www.arbios.com/. An archive of the presentation will be available for 90 days. About Arbios Arbios Systems, Inc. is a biomedical device company that, through its wholly-owned subsidiary, Arbios Technologies, Inc., is engaged in the discovery, acquisition and development of proprietary liver assist devices and new technologies useful in the diagnosis and treatment of acute liver failure. Arbios' products in development include SEPET(TM), a novel blood purification therapy and HepatAssist-2(TM), a bioartificial liver combining liver cell therapy and sorbent-based detoxification. DATASOURCE: Arbios Systems, Inc. CONTACT: Amy Factor, Chief Executive Officer of Arbios Systems, Inc., +1-973-377-7665, ; or Paula Schwartz, investors, +1-917-322-2216, or Pat Garrison, media, +1-917-322-2567, both of Rx Communications Group Web site: http://www.arbios.com/

Copyright